Amniotic Fluid Notes

Learning Outcomes

  • Function of Amniotic Fluid: Recognize role in protection, temperature stabilization, fetal movement, and lung development.
  • Formation and Composition: Understand how amniotic fluid is produced and its chemical makeup.
  • Differentiating Fluids: Differentiate maternal urine from amniotic fluid through testing.
  • Indications for Amniocentesis: Know when and why to perform amniocentesis.
  • Testing Procedures: Familiarize with procedures for testing amniotic fluid for bilirubin, fetal lung maturity, and cytogenetics.
  • Spectrophotometric Analysis: Discuss the principles and interpretation of analysis for fetal hemolytic disease.
  • Liley Graph Interpretation: Explain how to interpret results from a Liley graph.
  • Detection of Neural Tube Disorders: Understand testing methods for neural tube defects via amniotic fluid analysis.
  • Lecithin-Sphingomyelin (L/S) Ratio: Discuss its physiological significance in fetal lung maturity.
  • Phosphatidyl Glycerol Relationship: Know the connection of PG to fetal lung maturity assessment.
  • Lamellar Bodies: Define and describe significance to the assessment of fetal lung maturity.
  • Sources of Error: Recognize principles and potential errors in L/S ratio, Amniostat-FLM, lamellar body count, and Foam Stability Index.

Key Terms

  • Amniocentesis: Procedure to collect amniotic fluid.
  • Amnion: Membranous sac surrounding the fetus.
  • Amniotic Fluid: Fluid providing an environment for the developing fetus.
  • Cytogenetic Analysis: Testing of fetal cells for chromosomal abnormalities.
  • Fetal Lung Maturity (FLM): Assessment of the developmental status of the fetus's lungs.
  • Lamellar Bodies: Particles that carry surfactants in amniotic fluid.
  • Lecithin-Sphingomyelin Ratio (L/S Ratio): Indicator of fetal lung maturity based on surfactant levels.

Introduction to Amniotic Fluid Testing

  • Significance: Testing often involves understanding fetal health; constituents reflect fetal metabolism and maturation.
  • Testing and Advancement: Modern prenatal screening methods may reduce reliance on amniocentesis but can require confirmatory testing.

Function and Physiology of Amniotic Fluid

  • Functions: Protects the fetus, supports movement, stabilizes temperature, and aids lung development.
  • Volume Regulation:
    • Increases from ~60 mL at 12 weeks to 800-1200 mL by the third trimester.
    • Polyhydramnios (>1200 mL) and oligohydramnios (<800 mL) signify fetal distress.
  • Chemical Composition: Derived from maternal plasma, fetal urine, and respiratory secretions; contains substances like bilirubin, enzymes, and proteins for health assessments.

Differentiation of Urine and Amniotic Fluid

  • Methods: Chemical analysis of creatinine and urea levels; [+] fern test for membrane rupture.
  • Test Criteria: Urine generally has higher creatinine/urea levels than amniotic fluid.

Indications for Amniocentesis

  • Reasons for Referral:
    • Maternal age, family history of chromosomal disorders, abnormal screening tests, or previous fetal issues.
  • Testing Goals: Genetic disorders, maternal age considerations, abnormal ultrasound findings, or suspected fetal lung maturity issues.

Specimen Collection and Processing

  • Collection Techniques: Typically done transabdominally under ultrasound guidance. Discard initial samples to avoid contamination.
  • Handling Protocols: Protect specimens from light (bilirubin), keep refrigerated, and process immediately to prevent degradation.

Analyzing Amniotic Fluid

  • Tests Overview:
    • Bilirubin Scans: Determine severity of hemolysis in fetal blood.
    • Liley Graph: Visualize results indicating levels of hemolytic severity.
    • Lecithin-Sphingomyelin Ratio: Assess lung maturity based on surfactant levels.
    • Foam Stability Index: Quick test to check for adequate surfactant presence.
    • Lamellar Body Count: Indicator of surfactant production and fetus lung maturity.

Implications of Fetal Distress

  • Signs to Monitor: Elevated bilirubin levels indicating fetal hemolytic disease, evaluating lung maturity through phospholipid ratios.
  • Neural Tube Defects Analysis: Increased alpha-fetoprotein levels in both maternal and amniotic fluids indicate potential defects;
    • Consider acetylcholinesterase levels for confirmation.

Conclusion

  • Testing amniotic fluid is essential for monitoring fetal health and can indicate a variety of conditions, such as fetal distress, maturity, and genetic conditions. Understanding the composition, implications of tests, and specific protocols for handling and processing these samples is crucial for effective prenatal care.